SFXN4 and chronic obstructive pulmonary disease: The present study discovered a novel protein duo, reticulocalbin-1 and sideroflexin-4, making a breakthrough in understanding the downstream signalling in exacerbation COPD thereby leading to improved clinical management of the disease.